Insights On Trial Design

  1. Addressing Trial Design Hurdles Across Alzheimer’s Disease Stages 12/10/2025

    Explore how endpoint selection, rater training, and the strategic implementation of eCOA can help address the unique scientific, operational, and human considerations at each stage of AD.

  2. The Role Of FDA Initiatives In Early-Phase Oncology Trials 5/15/2025

    Project FrontRunner represents a paradigm shift in oncology drug development, championing earlier-line studies to bring novel treatments to patients sooner.

  3. Triple-Negative Breast Cancer: Global Clinical Trial Landscape 1/30/2025

    With over 1,500 TNBC-focused clinical trials since 2019, research efforts into Triple-negative breast cancer (TNBC) treatments are accelerating despite challenges such as drug resistance.

  4. The Golden Era Of GLP-1 Drugs 10/8/2024

    As GLP-1 drugs reshape the market, understanding their potential risks, applications, and economic effects is crucial for professionals in the pharmaceutical and healthcare industries.

  5. Evidence Generation Evolved 6/13/2024

    Explore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.

  6. Breaking Barriers In Drug Development: Time, Trust And Putting Patients First 1/16/2025

    Unpack systemic challenges in drug development that inflate costs and delay life-saving treatments. Learn about streamlining processes, fostering patient trust, and reallocating resources efficiently.

  7. We Can Fix What's Broken in Research—If We Solve the Right Problems 4/11/2025

    Addressing the root causes of inefficiencies in research is the only way to drive meaningful progress. Explore why tackling the right issues is essential to fixing broken research process.

  8. A Smartphone Based Biomarker For The Estimation Of Unipolar Depression Severity 3/28/2025

    The study investigates the potential of using smartphones and wearables to create objective biomarkers for mood disorders, specifically focusing on unipolar depression.

  9. Conducting Early Phase Clinical Trials In Diverse Healthy Populations 10/14/2025

    Download our guide to learn proven strategies for designing early phase clinical trials that successfully enroll diverse populations and meet FDA diversity guidance.

  10. The FDA's Timeline: Advancing Diversity In Clinical Trials 8/28/2024

    The FDA has issued multiple guidelines in recent years to enhance diversity in clinical trials. These efforts aim to ensure medical products are effective and safe for all populations.